Syringe Services Programs
Community programs providing sterile injection supplies plus overdose, testing, and treatment services.
SDG 3 Good Health & Well-beingWhat is it?
Syringe services programs (SSPs), sometimes called needle exchanges, provide sterile syringes and injection equipment and safely dispose of used ones. Modern SSPs are also hubs for naloxone, testing for HIV and hepatitis C, wound care, and referrals to treatment.
Why does it matter?
SSPs reduce the spread of blood-borne infections and connect a hard-to-reach population to health care and, often, to treatment. In rural areas hit by injection-driven HIV and hepatitis C outbreaks, they can be a critical line of defense.
How does it work?
People exchange or receive sterile supplies without judgment, which draws them into contact with staff who offer naloxone, fentanyl test strips, vaccinations, testing, and warm handoffs to medication-assisted treatment. Safe disposal reduces used syringes in the community.
Who benefits?
People who inject drugs benefit from lower infection and overdose risk, and the broader community benefits from reduced disease transmission, safer needle disposal, and increased treatment entry.
Who may be disadvantaged?
Communities can experience friction over siting and public perception, and programs may face legal or funding barriers; without adequate support, disposal and neighborhood concerns can go unmet.
What evidence exists?
CDC concludes that SSPs are safe, effective, and cost-saving, do not increase drug use or crime, and that participants are more likely to enter treatment than non-participants.
What tradeoffs exist?
SSPs deliver strong public-health returns but require sustained community engagement and funding; neglecting disposal logistics or local buy-in can undermine an otherwise effective program.
Common misconceptions
SSPs do not increase drug use or crime and do not lead to more discarded needles; evidence consistently shows the opposite. They are a gateway to care, not to addiction.
What you can do next
Understand how SSPs distribute naloxone and fentanyl test strips, and how the broader harm-reduction framework links survival to eventual treatment.